Lumen Posts $2.8B in Q2 Revenue, Reaffirms 2026 Outlook, and Names New Director
LUMN sits 88% above its 52-week low of $3.61.
Summary
Lumen Technologies reported Q2 2026 revenue of $2.805 billion, topping estimates, and reiterated its full-year outlook. The company also appointed John Hinshaw to its board, adding digital transformation and risk management expertise.
Key Events · Earnings and Guidance · LUMN
-
Q2 Revenue Beats Consensus
Revenue of $2.805 billion exceeded the $2.77 billion consensus, though down 9% year-over-year due to the Mass Markets divestiture.
-
Adjusted EBITDA and Free Cash Flow
Adjusted EBITDA excluding special items was $802 million (28.6% margin), and free cash flow excluding special items was $327 million, a significant improvement from $(209) million a year ago.
-
Full-Year 2026 Guidance Reiterated
Management reaffirmed its outlook for Adjusted EBITDA of $3.1-$3.3 billion and free cash flow of $1.9-$2.1 billion, reflecting confidence in the ongoing transformation.
-
Board Appointment Strengthens Oversight
John Hinshaw, former HSBC Group COO and technology executive, was appointed to the board, adding expertise in digital transformation and risk management as Lumen integrates Alkira.
Analysis · LUMN · Technology
Lumen's Q2 results delivered revenue of $2.805 billion, surpassing the $2.77 billion consensus, alongside a net loss of $(201) million, or $(0.20) per share. Adjusted EBITDA excluding special items reached $802 million, and free cash flow came in at $327 million. Reiterating its full-year 2026 guidance for Adjusted EBITDA of $3.1-$3.3 billion and free cash flow of $1.9-$2.1 billion, the company signaled confidence in its transformation. Adding further strength, the board appointed John Hinshaw—a former HSBC COO with deep technology and risk management experience—as Lumen integrates the Alkira acquisition and pivots toward digital networking.
At the time of this filing, LUMN was trading at $6.80 on NYSE in the Technology sector, with a market capitalization of approximately $6.9B. The 52-week trading range was $3.61 to $11.95. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.